Human breast cancer cell growth inhibition and deregulation of [Ca2+](i) by estradiol

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Estradiol inhibits the growth of human breast cancer MCF-7 cells at supramicromolar concentrations. The mechanism of such phenomenon remains to be unravelled. Confocal laser scanning microscopic studies suggest elevation of [Ca2+](i) preceding bleb formation and cellular injury following acute and chronic treatment of ionomycin and estradiol at supramicromolar concentration. Phase contrast morphological study demonstrates metaphase-arrested cells and giant multinuclear cells possibly due to lack of cytokinesis caused by estradiol. There is a striking similarity between the morphological changes caused by estradiol and enforced overexpression of cyclin-dependent kinase inhibitor p21(waf1/cip1). Such similarity together with the reported key role of intracellular ionized calcium [ca2+](i) in regulating cyclin and deregulation of [Ca2+](i) by estradiol raises the possibility of deregulation of gene expression leading to inhibition of cyclin-dependent proliferative signals participating in inhibition of growth in MCF-7 cells.

Cite

CITATION STYLE

APA

Jain, P. T., & Trump, B. F. (1997). Human breast cancer cell growth inhibition and deregulation of [Ca2+](i) by estradiol. Anti-Cancer Drugs, 8(3), 283–287. https://doi.org/10.1097/00001813-199703000-00010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free